Morgan Stanley
SGMT icon

Morgan Stanley’s Sagimet Biosciences SGMT Stock Holding History

Morgan Stanley’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$488K Buy
93,307
+4,063
+5% +$22.6K ﹤0.01% 5498
2025
Q4 		$528K Sell
89,244
-156,833
-64% -$1.13M ﹤0.01% 5485
2025
Q3 		$1.69M Buy
246,077
+50,583
+26% +$410K ﹤0.01% 4884
2025
Q2 		$1.49M Sell
195,494
-80,558
-29% -$340K ﹤0.01% 4890
2025
Q1 		$900K Sell
276,052
-2,143
-0.8% -$8.99K ﹤0.01% 5051
2024
Q4 		$1.25M Buy
278,195
+6,763
+2% +$34.3K ﹤0.01% 4974
2024
Q3 		$752K Sell
271,432
-67,761
-20% -$209K ﹤0.01% 5204
2024
Q2 		$1.16M Buy
339,193
+257,974
+318% +$1.18M ﹤0.01% 4870
2024
Q1 		$440K Buy
81,219
+57,391
+241% +$412K ﹤0.01% 5372
2023
Q4 		$129K Buy
23,828
+6,364
+36% +$30K ﹤0.01% 6079
2023
Q3 		$154K Buy
+17,464
New +$233K ﹤0.01% 5698

Other funds holding SGMT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.71B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return